177478-56-7

Upstream product

• 141-82-2 malonic acid 
• 90922-26-2 4-Acetamido-3-methoxybenzaldehyde 
• 38512-82-2 3-methoxy-4-nitrotoluene 
• 90151-40-9 4-amino-3-methoxybenzaldehyde 

Downstream Products

• 92288-42-1 3-<3-Methoxy-4-cyan-phenyl>-propionsaeure 
• 91819-02-2 3-<4-Amino-3-methoxy-phenyl>-propionsaeure 
• 93136-41-5 3-<4-Acetamino-3-methoxy-phenyl>-propionsaeure 

Relevant academic research and scientific papers

Benzimidazole compounds as bradykinin antagonists

PCT No. PCT/JP95/01478 Sec. 371 Date Feb. 3, 1997 Sec. 102(e) Date Feb. 3, 1997 PCT Filed Jul. 25, 1995 PCT Pub. No. WO96/04251 PCT Pub. Date Feb. 15, 1996This invention relates to a heterocyclic compound of the formula: wherein a group of the formula: is a group of the formula: etc., X is O, S or N-R5, R1 is lower alkyl, etc., R5 is hydrogen, lower alkyl, etc., R2 is hydrogen, halogen, lower alkyl, etc., R3 is halogen, lower alkyl, etc., R4 is amino optionally having suitable substituent(s), and A is lower alkylene, and a salt thereof, to processes for preparation thereof, and to a pharmaceutical composition comprising the same for the prevention and/or the treatment of bradykinin or its analogues mediated diseases in human being or animals.

Pyridopyrimidones, quinolines and fused N-heterocycles as bradykinin antagonists

This invention relates to a compound of the formula: STR1 wherein Z is a group of the formula: STR2 in which X1 is N or C--R1, X2 is N or C--R9, X3 is N or C--R2, R1 is lower alk

Heterocyclic compounds as bradykinin antagonists

This invention relates to a compound of formula (I) wherein A1 is lower alkylene, R1 is substituted quinolyl, etc., R2 is hydrogen, halogen or lower alkyl, R3 is halogen or lower alkyl, and R4 is a gr